ResearcherKeio UniversityActive in the last 2 years

Satoru Matsuda

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8441-2755; OpenAlex author ID A5066375443. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2026: 1 paper

Papers 1

Postoperative risk stratification after upfront surgery for resectable pancreatic ductal adenocarcinoma in the S-1 adjuvant era. Last author DOI 10.1016/j.pan.2026.05.008 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shutaro Hori · 1 shared paper, 2026 · strength 0.30
- Paper Postoperative risk stratification after upfront surgery for resectable pancreatic ductal adenocarcinoma in the S-1 adju… DOI 10.1016/j.pan.2026.05.008 ↗
Minoru Kitago · 1 shared paper, 2026 · strength 0.30
- Paper Postoperative risk stratification after upfront surgery for resectable pancreatic ductal adenocarcinoma in the S-1 adju… DOI 10.1016/j.pan.2026.05.008 ↗
Yuta Abe · 1 shared paper, 2026 · strength 0.30
- Paper Postoperative risk stratification after upfront surgery for resectable pancreatic ductal adenocarcinoma in the S-1 adju… DOI 10.1016/j.pan.2026.05.008 ↗
Masayuki Tanaka · 1 shared paper, 2026 · strength 0.30
- Paper Postoperative risk stratification after upfront surgery for resectable pancreatic ductal adenocarcinoma in the S-1 adju… DOI 10.1016/j.pan.2026.05.008 ↗
Yutaka Nakano · 1 shared paper, 2026 · strength 0.30
- Paper Postoperative risk stratification after upfront surgery for resectable pancreatic ductal adenocarcinoma in the S-1 adju… DOI 10.1016/j.pan.2026.05.008 ↗
Kohei Mishima · 1 shared paper, 2026 · strength 0.30
- Paper Postoperative risk stratification after upfront surgery for resectable pancreatic ductal adenocarcinoma in the S-1 adju… DOI 10.1016/j.pan.2026.05.008 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.